Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Stage Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04882033
What this trial is testing

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Limited Stage
Tianjin Medical University Cancer Institute and Hospital 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07798947
What this trial is testing

A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC

Who this might be right for
Limited-stage Small-cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT00527982
What this trial is testing

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT05742607
What this trial is testing

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

Who this might be right for
Non Small Cell Lung Cancer
Innate Pharma 70
Testing effectiveness (Phase 2)Looking for participantsNCT07091305
What this trial is testing

QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)ChemoradiotherapyInduction Therapy+1 more
Shanghai Chest Hospital 28
Testing effectiveness (Phase 2)Ended earlyNCT00545948
What this trial is testing

Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Duke University 31
Testing effectiveness (Phase 2)Ended earlyNCT00494026
What this trial is testing

Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 4
Testing effectiveness (Phase 2)Study completedNCT02046733
What this trial is testing

Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease

Who this might be right for
Limited Stage Small Cell Lung CancerSmall Cell Lung Cancer
ETOP IBCSG Partners Foundation 222
Not applicableStudy completedNCT00874211
What this trial is testing

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+4 more
SWOG Cancer Research Network 3,571
Testing effectiveness (Phase 2)Study completedNCT01165021
What this trial is testing

Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 19
Large-scale testing (Phase 3)Looking for participantsNCT06498635
What this trial is testing

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Who this might be right for
Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 306
Testing effectiveness (Phase 2)Ended earlyNCT03030131
What this trial is testing

Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 50
Not applicableUnknownNCT04171986
What this trial is testing

Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis

Who this might be right for
Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 93
Testing effectiveness (Phase 2)Temporarily pausedNCT06694454
What this trial is testing

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small Cell LungNon-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07722182
What this trial is testing

Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Chinese University of Hong Kong 100
Early research (Phase 1)WithdrawnNCT06427369
What this trial is testing

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung CancerLimited-stage Small-cell Lung CancerLung Non-Small Cell Carcinoma+2 more
Roswell Park Cancer Institute
Not applicableUnknownNCT03078959
What this trial is testing

Prognostic Value of PD-L1 in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fondazione Ricerca Traslazionale 350
Testing effectiveness (Phase 2)Looking for participantsNCT07559786
What this trial is testing

A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

Who this might be right for
SCLC, Limited Stage
Henan Cancer Hospital 200
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Testing effectiveness (Phase 2)UnknownNCT05034133
What this trial is testing

Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Beijing Haidian Hospital 20
Next Page